2023 Together - PH357 - Optimizing Biosimilar Adoption Using Strategy, a Multidisciplinary Approach and Financial Analysis - On Demand

This panel discussion will explore two successful provider journeys toward adoption of biosimilars. The panel will share steps your organization can take and pitfalls to avoid to effectively implement your biosimilar conversion initiatives. 

Target Audience

 

  • Nurses
  • Pharmacists
  • Pharmacy Technicians
  • Physicians
  • Other Healthcare Professionals

Learning Objectives

  • Describe how a team approach can drive biosimilar adoption.  

  • Explain what information is required to complete a thorough financial analysis to choose the optimal preferred biosimilar for your institution.  

  • Describe the steps needed to effectively implement biosimilar conversions at your institution.  

Course summary
Available credit: 
  • 0.75 ACPE Pharmacist
  • 0.75 ACPE Pharmacy Technician
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC
  • 0.75 General CE - Attendance
  • 0.75 Interprofessional Continuing Education (IPCE)
Course opens: 
09/07/2023
Course expires: 
09/22/2024
On Demand
United States

Faculty

Heather Warhurst, PharmD, MHA, Director of Drug Use Policy, Indiana University Health, Indianapolis, Ind. 

William Shaw, RPh, Director, Statewide Pharmacy Purchasing and Logistics, Indiana University Health, Indianapolis, Ind.  

Carmen Gust, PharmD, BCPS, DPLA, System Clinical Pharmacy Coordinator, ThedaCare, Appleton, Wis. 

Wendy Biese, PharmD, MHA, DPLA, System Director, Pharmacy Services, ThedaCare, Appleton, Wis. 

Disclosure

As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
 
Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
 
FDA Off-Label Use
 
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
 
Disclosure Statements
 
Absence of Relevant Financial Relationships
 
None of the planners, faculty, or others in a position to control content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Accreditation Statement

In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
 
 

Credit Types

Interprofessional Continuing Education (IPCE)

This activity was planned by, and for, the healthcare team, and learners will receive 0.75 Interprofessional Continuing Education (IPCE) credits for learning and change.

 

Nurses (CNE)

Vizient, Inc. designates this enduring material for a maximum of 0.75 ANCC contacts hours.

Pharmacists (CPE)

Vizient, Inc. designates this enduring material for a maximum of 0.75 contact hours for Pharmacists. 

Universal Activity Number: JA0006103-0000-23-201-H04-P

Pharmacy Technicians (CPE)

Vizient, Inc. designates this enduring material for a maximum of 0.75 contact hours for pharmacy technicians. 

Universal Activity Number: JA0006103-0000-23-201-H04-T

Physicians (CME)

Vizient, Inc. designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Healthcare Professionals (General CE Credit)

Vizient, Inc. will award a maximum of 0.75 contact hours to all other healthcare professionals who successfully complete the activity. These individuals will receive a Certificate of Participation indicating the maximum credits available.

Many state licensing boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.

 

Available Credit

  • 0.75 ACPE Pharmacist
  • 0.75 ACPE Pharmacy Technician
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC
  • 0.75 General CE - Attendance
  • 0.75 Interprofessional Continuing Education (IPCE)
Please login or register to take this course.

 

Select the Obtain Credit button to access the activity.